Haichuang Pharmaceutical: Net loss of 29.88M yuan in the first quarter

Haichuang Pharmaceutical Announcement, operating revenue in the first quarter of 2026 is 26.0255 million yuan.
Net loss attributable to shareholders of the listed company is 29.88M yuan, compared to a net loss of 32.1018 million yuan in the same period last year.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin